Tag: Biotech
Daiichi Sankyo initiates phase 3 trial of mRNA based covid vaccine
The trial is an active-controlled, trial to investigate the non-inferiority of DS-5670 to an already-approved mRNA vaccine
US FDA issues observations for Biocon Biologics sites
At the conclusion of these inspections, the agency has issued Form 483s with 11 observations each for the two sites in Bengaluru and 6 observations for the Malaysia site
Dr Jitendra Singh interacts with startup founders at Venture Center, Pune
Venture Center incubatee startups reported Rs 377 crore in revenue and raised Rs 97 crore of funding in FY 2021-22.
Growing investment in biotech startups likely to make CAR-T therapies affordable...
Increased investments likely to boost the research and production capabilities and eventually makes the therapies affordable to those in need, says GlobalData, a leading data and analytics company.
Innovation to remain the key to pipette tips market growth
The demand for pipette tips increased dramatically as a result of the COVID-19 outbreak
GEAC clearance mandatory for environmental release of GM crops: Minister
Applications are considered by GEAC as per the provisions of the Rules, 1989 and amendments thereafter
Technology meets sustainability & innovation at Agilent’s First Future Lab Summit
Agilent also launched two new products from its gas/liquid chromatography (GC/LC) mass spectrometry (MS) product lines
Study reveals big step towards better treatment of Alzheimer’s disease
Scientists demonstrate the influence of nanoparticles and surrounding ions on the formation of β-sheet structure in amyloid β proteins
IIT Madras researchers develop artificial intelligence tool towards personalized cancer diagnosis
Known as ‘PIVOT,’ the tool helps identify cancer-causing genes and aids in better recovery for patients besides reducing side effects and is based on a model that utilizes information on mutations
Avantor named best company for upstream processing & single-use solutions at...
Awards recognize Avantor innovations that allow the biopharmaceutical industry to bring therapies to market more efficiently